Scientists around the world have painstakingly assembled the genetic sequences for everything from corn to E. coli to humans. But the genetic sequence is only a starting point—most of the work in a cell is done by proteins, which are created from the genetic sequence but then folded into complex 3-D configurations to carry out their functions. Knowing the shapes of the proteins is crucial for understanding how cells work and, for example, designing drugs to work on diseases. But predicting how a protein would fold based solely on its genetic data remained elusive for decades.
DeepMind released an open-source version of a program called AlphaFold in July 2021, which has proved extraordinarily good at predicting the shapes proteins will take. Since then, according to Nature, it has been used by more than half a million researchers and resulted in thousands of papers on topics ranging from antibiotic resistance to crop resilience.
Jumper said, "What I love about all of this is…we could draw a straight line from what we do to people being healthy because of what we learn about biology in the cell and everything else, and it’s just extraordinary."
Jumper received his Ph.D. in theoretical chemistry from the University of Chicago in 2017; his thesis examined how to apply machine-learning techniques to the study of protein dynamics. He was advised by Profs. Karl Freed and Tobin Sosnick, and afterward worked as a postdoctoral researcher in Sosnick’s lab before moving to Google DeepMind.
Freed is the Henry G. Gale Distinguished Professor Emeritus of Chemistry. Tobin Sosnick is the William B. Graham Professor of Biochemistry and Molecular Biology, and currently serves as chair of the department.
In 2023, Sosnick wrote, "Following the July 2021 online publication of AlphaFold, I sent my colleagues an email with the subject line 'Revolution in structural biology'...The expression "I alphafolded it" is now something I hear almost every day, whether in the lab, during a thesis defense, or at a scientific conference. This transformation of a noun into a verb, akin to the phrase, "I googled it," mirrors the revolution that has occurred in biological sciences over the past two and a half years."
Jumper is the 19th person affiliated with the University of Chicago to receive the Nobel Prize in Chemistry. Most recently, the 2023 Nobel Prize in Chemistry was awarded to Moungi Bawendi, PhD’88, for the discovery of quantum dots; and the 2019 prize to John Goodenough, PhD’52, for the invention of lithium batteries.
"What a joy to see our alumni, John Jumper and Moungi Bawendi, recognized with Nobel Prizes two years in a row!" said Prof. Jiwoong Park, chair of UChicago's Department of Chemistry. "Dr. Jumper's Nobel recognition is a testament to the pioneering research conducted at UChicago chemistry, leading to real-world impacts, and the success of our mission to train future leaders in the field of chemistry."
Park added that Jumper is scheduled to deliver the 2025 Bloch Lecture at UChicago, "so we’re looking forward to welcoming him back to campus next year."